Using RNAi to Target PRDMs in Cancer
Time: 2:00 pm
day: Day One
Details:
- ARIZ is developing siRNA candidates targeting upregulated PRDM isoforms in cancer
- PRDM2 isoform RIZ2 is highly overexpressed in lung cancer
- Success in extrahepatic siRNA delivery using a targeted calcium phosphate nanoparticle delivery system
